M&A / Deals Lilly puts up to $2.75bn into Insilico alliance PharmaphorumInsilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment.M&A / DealsRead full story pharminent March 29, 2026 (Last updated: March 30, 2026) Pharmaphorum Insilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment. M&A / DealsRead full story Post navigation Previous: S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLCNext: Otsuka grows in neuroplastogens with $1.225bn Transcend buy Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
